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a  b  s  t  r  a  c  t
Huperzine  A, a Lycopodium  alkaloid  produced  by Chinese  folk  herb  Huperzia  serrata  (Lycopodiaceae),
has  been  shown  to be  a promising  agent  for the  treatment  of  Alzheimer’s  disease  due to its  potent
acetylcholinesterase  (AChE)  activity,  as  well  its  efﬁcacy  in  the  treatment  of memory  of  aged patients.  Thus,
the effects  of  two  Huperzia  species  of habitats  in  Brazil  (H.  quadrifariata  and  H. reﬂexa)  with  described
in  vitro  AChE  inhibition  activities  were  studied  and  their  effects  on mice  brain  AChE  inhibition  were
determined  after  a single  intraperitoneal  (i.p.) injection.  The  alkaloid  extracts  were  administered  to  mice
in various  doses  (10,  1 and  0.5  mg/kg)  and  acetylcholinesterase  activity  was  measured  post  mortem  in
two brain  areas  using  the  Ellman’s  colorimetric  method.  The  AChE  activity  was  found  to  be  signiﬁcantly
reduced  in both  the  cortex  and  hippocampus,  although  this  activity  was  less  potent  than  that  of  reference
inhibitor  huperzine  A  (0.5  mg/kg).  Thus,  it appears  that  H.  quadrifariata  and  H.  reﬂexa  alkaloid  extracts,
shown  to  inhibit  acetylcholinesterase  in  vitro,  also  have  very  potent  in vivo  effects,  suggesting  that  the
Huperzia  species  may  still  constitute  a  promising  source  of compounds  with pharmaceutical  interest  for
Alzheimer’s  disease.ntroduction
Cholinesterase inhibitors are currently still the only approved
rugs for the treatment of patients with mild to moderately severe
lzheimer’s disease, a neurodegenerative disorder with progres-
ive deﬁciency of memory and cognitive function (Bartus et al.
982; Cummings 2004). The cholinergic hypothesis postulates
hat memory impairment in patients with Alzheimer’s disease
esults from a deﬁcit in cholinergic function in the brain. The most
mportant changes observed are a decrease in the acetylcholine
eurotransmitter, as well in levels of the respective enzymes that
ynthesize and degrade acetylcholine, choline acetyltransferase
nd acetylcholinesterase (AChE) (Perry et al. 1977; Bowen et al.
982). As such, AChE inhibitors can restore the levels of acetyl-
holine by inhibiting AChE; however none of these agents have the
bility to stop disease progression.Huperzine A, an alkaloid isolated from the Chinese herb Huperzia
errata (Lycopodiaceae), is a reversible, potent and selective AChE
nhibitor with a longer duration of action and the ability to cross the
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blood–brain barrier. This compound induces signiﬁcant improve-
ments in the memory of aged patients with Alzheimer’s disease
with fewer noticeable side effects (Tang et al. 1999; Tang and Han
1999). As such, in an attempt to ﬁnd other AChE inhibitors of plant
origin within the family Lycopodiaceae, we have recently screened
alkaloids extracts from four Huperzia and one Lycopodiella species
from Brazil for their in vitro enzymatic inhibitory effects (Konrath
et al., 2012b) and also the in vitro and ex vivo effects of Lycopodium
clavatum and L. thyoides on AChE (Konrath et al. 2012a). Among
these, the extracts of Huperzia reﬂexa (Lam.) Trevis and Huperzia
quadrifariata (Bory) Rothn. showed the greatest anticholinesterase
activity with a selectivity for the true acetylcholinesterase; with
IC50 = 0.11 and 2.0 g/ml, respectively. These effects are attributed
to the Lycopodium alkaloids present in the extracts, a group of com-
pounds obtained from club mosses belonging to the Lycopodiaceae
family, found to possess potent anticholinesterase activity (Liu et al.
1986; Liu and Huang 1994; Ma  and Gang 2004). Within this class of
plant metabolites, only a few of these have been demonstrated to be
acetylcholinesterase inhibitors, including huperzine A, which also
Open access under the Elsevier OA license. has a reported effect on improving memory and learning (Vincent
et al. 1987; Zhang and Wang 1990).
Based on this evidence, the aim of the present study was
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he anticholinesterase effects of H. quadrifariata and H. reﬂexa,
sing an in vivo model, in an attempt to correlate the results
btained, together with the chemical characterization of the above-
entioned extracts. The ﬁndings from the present study suggest
hat H. quadrifariata and H. reﬂexa may  be sources of candidate




Acetylthiocholine iodide, 5,5′-dithiobis-(2-nitrobenzoic acid)
DTNB), 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
romide (MTT) and huperzine A were obtained from Sigma Chem-
cal Co (USA). Dimethyl sulfoxide (DMSO) and the buffer salts were
urchased from Merck (Germany). Water was treated in a Milli-Q
Millipore, Bedford, Massachusetts) water puriﬁcation system. All
ther reagents and organic solvents were of the highest grade
vailable. The extracts were lyophilized and initially dissolved in
MSO; solutions were then diluted in saline immediately before
ach administration.
lant material
Aerial parts of Huperzia quadrifariata (0.58 kg) and Huperzia
eﬂexa (0.092 kg) were collected in Rio Grande do Sul, Brazil, in April
009 and July 2008, respectively. The material was identiﬁed and
uthenticated by Prof. Dr. Sérgio de Loreto Bordignon of the Centro
niversitário La Salle. Voucher specimens (HAS 47475 and 45877)
ave been deposited in the Fundac¸ ão Zoobotânica do Rio Grande
o Sul Herbarium for future reference.
reparation of extracts and chemical composition
Air dried aerial parts were ground and separately defatted with
-hexane using a Sohxlet extractor for 2 days. The remaining plant
aterials were subsequently extracted with EtOH by the same pro-
edure, until the eluate was  negative to Dragendorff’s reagent. The
tOH extracts were concentrated under vacuum; the dry residues
ere suspended in 5% HCl and washed with CH2Cl2. The aque-
us layers thus obtained, were basiﬁed with NH4OH (pH 11) and
artitioned with CH2Cl2, affording, after ﬁltration under Na2SO4,
rude alkaloid extracts (AE). Huperzia quadrifariata AE (HQAE) and
uperzia reﬂexa AE (HRAE) were then submitted to a GC–MS analy-
is on a Perkin–Elmer Qmass-910 apparatus with a SE 30 capillary
olumn of 30 m in length in order to verify the chemical composi-
ion. The injection volume was 0.5 l with He as carrier, with the
ow rate being 1 ml/min. Temperature program: 140 ◦C (3 min),
40–250 ◦C at 5 ◦C/min, 250 ◦C (5 min), 250–280 ◦C at 5 ◦C/min,
80 ◦C (5 min). The temperatures of the injector, interface and ion
ource were 300, 280 and 280 ◦C respectively. The ionization energy
as 70 eV and individual alkaloid identiﬁcations were made by
omparing breakdown patterns with those found in the litera-
ure and with our own library of isolated Lycopodium alkaloids
MacLean 1963; Alam et al. 1964; Sun et al. 1993; Ortega et al.
004) (Figs. S1 and S2).
nimals and care
Swiss albino male mice of the CF1 strain (25–35 g), obtained
rom the Fundac¸ ão Estadual de Produc¸ ão e Pesquisa em Saúde
FEPPS) were used. Animals were housed in plastic cages and main-
ained at 22–23 ◦C under a 12 h light/dark cycle (lights on at 7:00
.m.) with free access to food and water. All experiments werene 19 (2012) 1321– 1324
conducted blind to the treatment condition of the animals and fol-
lowing the USA National Institute of Health Guidelines for Animal Care
and Use and approved by the Animal Care and Ethics Committee of
the Universidade Federal do Rio Grande do Sul.
Ex vivo acetylcholinesterase inhibition assay
Groups of six Swiss albino male mice were treated i.p.
(0.1 ml/10 g) with different doses of HRAE (10, 1, 0.5 and 0.1 mg/kg),
HQAE (10, 1 and 0.5 mg/kg) and huperzine A (0.5 mg/kg). The con-
trol animals received the same volume of saline and 20% DMSO
(administration vehicle). Mice were sacriﬁced 60 min  later, brains
were quickly removed on an ice-cold plate; cortex and hippocampi
were dissected out and homogenized in 10 volumes of cold 20 mM
phosphate buffer (pH 7.4). The homogenates were centrifuged
at 10,000 × g for 10 min  and the supernatants were employed as
sources of enzyme. All steps were carried out at 4 ◦C and the
total AChE activity was determined using the spectrophotometric
method of Ellman et al. (1961).  Each brain homogenate preparation
was mixed with a buffered solution of Ellman’s reagent (10 mM
DTNB) and acetylthiocholine at a concentration of 0.8 mM.  Hydrol-
ysis rates were measured at 415 nm for 3 min  with 30 s intervals,
monitored by the formation of the thiolate dianion of DTNB. Per-
centages of inhibitions were calculated by comparing AChE activity
in the aliquots of brain homogenates with activity of mice treated
just with DMSO.
Protein assay
Total protein concentrations were determined as described by
Lowry et al. (1951),  using bovine serum albumin as standard.
Statistics
All assays were performed in triplicate and the mean was used
for statistical analysis. Data were analyzed by ANOVA followed by
Duncan’s multiple range test when the F test was signiﬁcant. Statis-
tical analyses were performed using the Statistical Package for the
Social Sciences (SPSS) software using a PC-compatible computer.
Results and discussion
After the discovery that the alkaloid huperzine A is a potent
acetylcholinesterase inhibitor and, consequently, very important
for the symptomatic treatment of Alzheimer’s disease, the interest
in the isolation and characterization of alkaloids from Lycopodi-
aceae has increased exponentially (Liu et al. 1986; Ma  and Gang
2004). However, due to the low alkaloid content and the very
limited distribution of H. serrata, other alternative sources are cur-
rently under investigation to obtain huperzine A in large quantities.
Endophytic fungi associated with H. serrata were also found to
synthesize this alkaloid, becoming an alternative way to produce
huperzine A, thus eliminating the need to harvest and extract wild
populations of Huperzia (Wang et al. 2011).
In this respect, we initiated the study of some species belonging
to this family with habitats in Brazil; the results of our previous
studies showed a promising in vitro inhibiting effect upon acetyl-
cholinesterase activity (Konrath et al., 2012b), which prompted us
to further investigate in vivo models in order to better characterize
such effects.
Figs. 1 and 2 show the effects of HQAE (10–0.5 mg/kg) and HRAE
(10–0.1 mg/kg) on AChE activity in the hippocampus and cortex of
mice. The experimental conditions were validated with huperzine
A (0.5 mg/kg), which inhibited the enzyme in all brain regions (64%
in cortex and 47.5% in hippocampus) (p < 0.05). As already reported,
DMSO was devoid of effect (p > 0.05) (Siqueira et al.  2003), with no
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Fig. 1. Effect of the acute administration of the alkaloid extract of H. quadrifariata,
HQAE (0.5, 1 and 10 mg/kg i.p.) and huperzine A (0.5 mg/kg i.p.), on AChE activity in




































































Fig. 2. Effect of the acute administration of the alkaloid extract of H. reﬂexa, HRAE
(0.5,  1 and 10 mg/kg i.p.) and huperzine A (0.5 mg/kg i.p.) on AChE activity in the
mouse cortex and hippocampus. Enzyme activity is expressed as the percentage of
control (DMSO-treated mice); all assays were performed in triplicate. Each valuef  control (DMSO-treated mice); all assays were performed in triplicate. Each value
epresents mean ± S.E.M. (n = 6). *p < 0.05 vs control (DMSO); # p < 0.05 vs previous
ose, Duncan’s test comparison after ANOVA.
igniﬁcant differences when compared to saline-treated groups.
QAE inhibited enzyme activity in the cortex, at all doses tested
Fig. 1A), achieving 50.4, 33 and 17% of inhibition (p < 0.05), for 10,
 and 0.5 mg/kg, respectively, while in hippocampus the effect was
ess marked, with signiﬁcant values of inhibition of 31 and 20.5%
Fig. 3. Structures of the Lycopodium alkaloids identiﬁed in Huperziarepresents mean ± S.E.M. (n = 6). *p < 0.05 vs control (DMSO); # p < 0.05 vs previous
dose, Duncan’s test comparison after ANOVA.
for 10 and 1 mg/kg (Fig. 1B). The AChE activity was  also markedly
affected by HRAE administration, with a 74, 56 and 43% of inhi-
bition (p < 0.05) in the cortex (Fig. 2A) and 53, 22 and 17% in the
hippocampus (Fig. 2B) for 10–0.5 mg/kg, respectively. Only after
the administration of the AE at a lower dose (0.1 mg/kg) did the
extract show no signiﬁcant activity on the enzyme in brain struc-
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ures (p > 0.05), showing that the alkaloid content in Huperzia reﬂexa
ossesses a better anticholinesterase inhibitory proﬁle when com-
ared to Huperzia quadrifariata.
The results obtained in the current study suggest that one or
ore alkaloids present in the extracts reach the brain following
ntraperitoneal administration, crossing the blood–brain barrier
nd inhibiting cholinesterase in selected brain areas, consistent
ith evidence of the already described inhibition of the brain
nzyme in vitro. The proﬁle of inhibition demonstrated that AChE
as preferentially affected in mice cortex following the injection of
lkaloids. Although spatial learning and memory are closely related
o hippocampal function in rodents (Moser et al.  1993), cholin-
rgic deﬁcits in both the hippocampus and cortex may  occur in
lzheimer’s disease, together with atrophy of surviving cholinergic
eurons in the basal forebrain in aged animals (Muir 1997).
Ten Lycopodium alkaloids belonging to lycopodane and ﬂa-
ellidane groups were detected in the extracts by means of
C–MS (Fig. 3). Among these, clavolonine, acetylclavolonine,
ycopodine, 6-hydroxylycopodine and sauroine were found in
QAE, while the presence of the alkaloids lycopodine, 6-
ydroxylycopodine, lycodoline, anhydrolycodoline, -obscurine,
es-N-methyl--obscurine and lycodine was conﬁrmed in HRAE,
long with other alkaloid compounds whose structures have not yet
een determined (Konrath et al., 2012b). It has been reported that
pproximately 200 alkaloids were isolated from different species of
his family; some of them exhibit a prominent anticholinesterase
ctivity including huperzine B, N-demethylhuperzinine and siebol-
ine A (Shen and Chen 1994; Hirasawa et al. 2003). In this study,
e demonstrated that alkaloids present in the extracts mani-
ested AChE inhibitory activity, although they are less potent
han huperzine A. However, none of the alkaloids detected in
he extracts surprisingly correspond with any known acetyl-
holinesterase inhibitor within this class of compounds. It should
e remembered, though, that active doses of the extracts are likely
o be diminished with further puriﬁcation of active compounds. As
uch, a bioassay-guided fractionation of the extracts will be con-
ucted in order to identify and isolate the active alkaloid/s, since
nly a few of these have reported anti-AChE activity, as shown
y in vitro assays, and none of them have demonstrated activity
n vivo.
Thus, our study demonstrates that the species, Huperzia quadri-
ariata and Huperzia reﬂexa,  appear to demonstrate newly identiﬁed
nd important anticholinesterase activity, corroborating our previ-
us results. Further research is also necessary to deﬁne the actual
otential of the use of these agents in humans, using other mod-
ls of Alzheimer’s disease. In addition, pharmacological evaluation
ith isolated alkaloids is in progress in our laboratory.
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